Evaluation of a new heparin agent in percutaneous coronary intervention: results of the phase 2 evaluation of M118 IN pErcutaNeous Coronary intErvention (EMINENCE) Trial.

Evaluation of a new heparin agent in percutaneous coronary intervention: results of the phase 2 evaluation of M118 IN pErcutaNeous Coronary intErvention (EMINENCE) Trial.

Item
http://www.wikidata.org/entity/Q33389032
Pharmacotherapy in the cardiac catheterization laboratory: evolution and recent developmentsNew parenteral anticoagulants in development.New antithrombotic drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesEmerging anticoagulants.Inhibitors of propagation of coagulation: factors V and X.New targets for glycosaminoglycans and glycosaminoglycans as novel targets.Contemporary anticoagulation therapy in patients undergoing percutaneous intervention.Developing drugs for use before, during and soon after percutaneous coronary intervention.The effects of heparins on the liver: application of mechanistic serum biomarkers in a randomized study in healthy volunteers.Impaired bioavailability and antiplatelet effect of high-dose clopidogrel in patients after cardiopulmonary resuscitation (CPR).
P2860

Evaluation of a new heparin agent in percutaneous coronary intervention: results of the phase 2 evaluation of M118 IN pErcutaNeous Coronary intErvention (EMINENCE) Trial.

Item
http://www.wikidata.org/entity/Q33389032
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Evaluation of a new heparin ag ...... intErvention (EMINENCE) Trial.
@ast
Evaluation of a new heparin ag ...... intErvention (EMINENCE) Trial.
@en
type
label
Evaluation of a new heparin ag ...... intErvention (EMINENCE) Trial.
@ast
Evaluation of a new heparin ag ...... intErvention (EMINENCE) Trial.
@en
prefLabel
Evaluation of a new heparin ag ...... intErvention (EMINENCE) Trial.
@ast
Evaluation of a new heparin ag ...... intErvention (EMINENCE) Trial.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Evaluation of a new heparin ag ...... intErvention (EMINENCE) Trial.
@en
P2093
P304
P31
P356
10.1161/CIRCULATIONAHA.109.913277
P407
P433
P478
P577
P698
P921